SLC2A1 and neoplasm: However, there was no significant connection between GLUT-1 and other clinical features including tumor differentiation (n=6, OR=1.59, 95% CI=0.82–3.07, p=0.166, Figure 4), age (n=4, OR=1.12, 95% CI=0.83–1.51, p=0.455, Figure 4), or tumor size (n=3, OR=1.12, 95% CI=0.82–1.52, p=0.48, Figure 4).